Inhibrx Biosciences (INBX) earnings, Aug 13, 2026: EPS −26%, stock −8.9%
In brief
Inhibrx Biosciences reported on Aug 13, 2026. Earnings per share changed −26% year over year, 2.6% below the estimate; revenue −100%. The stock opened with a −5.4% gap and closed the day −8.9% (Aug 14, 2026). The stock is now 48.3% below its 52-week high, −2.4% over 12 months. Next report: Nov 13, 2026.
EPS vs estimate−2.6%
EPS, YoY−26%
Revenue, YoY−100%
Gap · day−5.4% · −8.9%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 14, 2026 | +2.1% | −6.5% |
| Aug 13, 2026 | −5.4% | −8.9% |
Next-quarter estimates, ratings and the INBX chart are in the terminal.
Open the terminalFAQ
When is Inhibrx Biosciences's next earnings report?
Nov 13, 2026. The date comes from daily data and is corrected if the company moves it.
How did Inhibrx Biosciences stock react to the report?
Opening gap −5.4%, day's result −8.9%.
Did Inhibrx Biosciences's earnings grow?
Earnings per share fell 26% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.